USFDA Approved Latest Drug for Lung Cancer Patients
Beacon Pharmaceuticals Limited, the leading oncology company in Bangladesh, has introduced a groundbreaking treatment for lung cancer: Tagrix, the first global generic version of osimertinib.
Learn more
Contact us
At Beacon Pharmaceuticals, your well-being is paramount. Count on us for any critical health concerns. With unwavering support, we're here to guide you towards a healthier tomorrow.
Adverse Event Reporting
Your Safety Matters! At Beacon Pharmaceuticals, we prioritize your well-being. Learn how to report any adverse events or side effects related to our products and contribute to safer healthcare.
Product complain Reporting
Your Feedback is Valued! At Beacon Pharmaceuticals, we take your concerns seriously. Report any product issues or complaints to help us maintain the highest quality standards in our pharmaceuticals.
Media Inquiry
Seeking information or interviews? Contact our media relations team at Beacon Pharmaceuticals for timely responses and insights into our latest developments and innovations in the pharmaceutical industry.
Beacon Pharmaceuticals Ltd.
Address
BEACON Business Centre9/B/2, Toyenbee Circular Road, Motijheel, Dhaka-1223, Bangladesh
Call Us
Email Us
Visit Us
Contact Us
Please know that we read all the messages sent to us. However, due to the large volume of messages we receive, you may not get a personal reply. Please note, fields marked with an asterisk (*) are required to be filled out.
Adverse Event Reporting
Please fill out the form below: Please note, fields marked with an asterisk (*) are required to be filled out.
Product Complain Reporting
Please fill out the form below: Please note, fields marked with an asterisk (*) are required to be filled out.
Media Inquiry
Please fill out the form below: Please note, fields marked with an asterisk (*) are required to be filled out.